Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Antitrust Division

                    Notice is hereby given that, on July 12, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301*et seq.*                     (“the Act”), Pistoia Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Context Matters, Inc., New York, NY; InfoChem GmbH, Munich, GERMANY; AMRA (Advanced MR Analytics AB), Linkoping, SWEDEN; Transcriptic Inc., Menlo Park, CA; WuXi AppTec, Shanghai, PEOPLE'S REPUBLIC OF CHINA; Chris L. Waller (individual), Brookline, MA; Eli Lilly and Company, Indianapolis, IN; VWR International, Darmstadt, GERMANY; and Ontoforce NV, Ghent, BELGIUM, have been added as parties to this venture.                

Also, Takeda Pharmaceutical Company, Ltd. (as subsidiary Millennium Pharma, Inc.), Cambridge, MA, has withdrawn as a party to this venture.

No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Pistoia Alliance, Inc. intends to file additional written notifications disclosing all changes in membership.

                    On May 28, 2009, Pistoia Alliance, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the                     **Federal Register**                     pursuant to Section 6(b) of the Act on July 15, 2009 (74 FR 34364).                

                    The last notification was filed with the Department on April 24, 2017. A notice was published in the                     **Federal Register**                     pursuant to Section 6(b) of the Act on May 22, 2017 (82 FR 23298).                

Patricia A. Brink,

Director of Civil Enforcement, Antitrust Division.

[FR Doc. 2017-17334 Filed 8-15-17; 8:45 am]

 BILLING CODE P